USER INTERFACE FEATURE FOR DRUG DELIVERY SYSTEM

• US 20130046279A1
• Filed: 08/16/2011
• Published: 02/21/2013
• Est. Priority Date: 08/16/2011
• Status: Abandoned Application

• Current Assignee: Cilag Gmbh International (Johnson & Johnson)
• Original Assignee: Cilag Gmbh International (Johnson & Johnson)
• Inventors: Niklewski, Paul J., Martin, James F., Mueller, Donn C., Feng, David Q., Krogh, Ross G., Jampala, Hemant
• Application Number:
  US13/210,530
• Publication Number:
  US 20130046279A1
• Time in Patent Office: Days
• US Class Current: 604/503
• CPC Class Codes: G16H 20/13 delivered from dispensers

Abstract

A medical system includes a monitoring unit and a drug delivery unit. The monitoring unit is operable to monitor at least one physiological parameter of a patient. The drug delivery unit includes an integral volume of a drug. A control logic is in communication with the monitoring unit and the drug delivery unit and is operable to regulate delivery of the drug to the patient from the integral volume, based on data associated with the at least one physiological parameter of the patient, in accordance with a safety shell control algorithm. A user interface feature is operable to receive input indicating administration of an external drug to the patient. The safety shell control algorithm responds to inputs received through the user interface feature indicating administration of an external drug to the patient, such as by modifying subsequent drug delivery regulation based on the administration of the external drug.

Claims

1. A medical system, comprising:

(a) a monitoring unit, wherein the monitoring unit is operable to monitor at least one physiological parameter of a patient;

(b) a drug delivery unit, wherein the drug delivery unit is in communication with the monitoring unit, wherein the drug delivery unit includes at least one integral volume of one or more drugs;

(c) a control logic configured to execute a safety shell control algorithm, wherein the control logic is in communication with the monitoring unit and the drug delivery unit, wherein the drug delivery unit is operable to regulate delivery of at least one of the one or more drugs to the patient from the integral volume based on data associated with the at least one physiological parameter of the patient in accordance with the safety shell control algorithm; and

(d) a user interface feature in communication with the control logic, wherein the user interface feature is operable to receive input indicating administration of an external drug to the patient, wherein the safety shell control algorithm is configured to respond to inputs received through the user interface feature indicating administration of an external drug to the patient.

2. The medical system of claim 1, wherein the drug delivery unit includes a removable cassette and an associated fluid container defining the integral volume of one or more drugs.

3. The medical system of claim 2, wherein the external drug is external to the removable cassette and associated fluid container.

4. The medical system of claim 1, wherein the drug delivery unit is operable to at least partially automate delivery of at least one of the one or more drugs to the patient from the integral volume based on data associated with the at least one physiological parameter of the patient in accordance with the safety shell control algorithm.

5. The medical system of claim 4, wherein the safety shell control algorithm is configured to change automated drug delivery from the integral volume in response to inputs received through the user interface feature indicating administration of an external drug to the patient.

6. The medical system of claim 1, wherein the monitoring unit is operable to monitor a plurality of physiological parameters of a patient, wherein the safety shell control algorithm is configured to process a first physiological parameter of a patient before receiving an input through the user interface feature indicating administration of an external drug to the patient, wherein the safety shell control algorithm is configured to process a second physiological parameter of a patient in response to receiving an input through the user interface feature indicating administration of an external drug to the patient.

7. The medical system of claim 1, wherein the safety shell control algorithm is configured to trigger an alarm in response to a first set of conditions associated with one or both of the monitoring unit or the drug delivery unit before receiving an input through the user interface feature indicating administration of an external drug to the patient, wherein the safety shell control algorithm is configured to trigger an alarm in response to a second set of conditions associated with one or both of the monitoring unit or the drug delivery unit after receiving an input through the user interface feature indicating administration of an external drug to the patient.

8. The medical system of claim 1, wherein the user interface feature comprises a button presented by the drug delivery unit.

9. The medical system of claim 1, wherein the user interface feature is operable to receive inputs indicating one or both of the type of external drug being delivered or the amount of external drug being delivered.

10. The medical system of claim 1, wherein the user interface feature comprises a set of graphical elements configured for selective enablement.

11. The medical system of claim 1, wherein the safety shell control algorithm is configured as a nodal network.

12. The medical system of claim 11, wherein each node of the nodal network is associated with a single function of the drug delivery unit or a single function of the monitoring unit.

13. The medical system of claim 11, wherein the nodal network is formed as a neural network.

14. The medical system of claim 11, wherein the safety shell control algorithm further employs fuzzy logic.

15. The medical system of claim 1, wherein the user input is further configured to receive additional input relating to patient demographics, wherein the safety shell control algorithm is responsive to input relating to patient demographics.

16. The medical system of claim 15, wherein the patient demographics include one or more of patient age, patient gender, and patient weight.

17. The medical system of claim 1, wherein the safety shell control algorithm is configured to trigger an alarm in response to at least one trend in patient physiological data from the monitoring unit.

18. The medical system of claim 17, wherein the safety shell control algorithm is configured to monitor trends in patient physiological data from the monitoring unit by using a linear best fit.

19. A medical system, comprising:

(a) a monitoring unit, wherein the monitoring unit is operable to monitor at least one physiological parameter of a patient;

(b) a drug delivery unit, wherein the drug delivery unit is in communication with the monitoring unit, wherein the drug delivery unit includes an integral volume of one or more drugs;

(c) a control logic configured to execute a safety shell control algorithm, wherein the control logic is in communication with the monitoring unit and the drug delivery unit, wherein the drug delivery unit is operable to perform one or both of the following based on data associated with the at least one physiological parameter of the patient in accordance with the safety shell control algorithm;

(i) regulate delivery of at least one of the one or more drugs to the patient from the integral volume, or

(ii) provide an alarm to a user; and

(d) a user interface feature in communication with the control logic, wherein the user interface feature is operable to receive input indicating administration of an external drug to the patient, wherein the safety shell control algorithm is configured to respond to inputs received through the user interface feature indicating administration of an external drug to the patient.

20. A method of operating a medical system, wherein the medical system comprises a monitoring unit and a drug delivery unit, wherein the monitoring unit is operable to monitor at least one physiological parameter of a patient, wherein the drug delivery unit includes an integral volume of one or more drugs, wherein the drug delivery unit is operable to deliver at least one of the one or more drugs to the patient from the integral volume, based at least in part on data associated with the at least one physiological parameter, the method comprising:

(a) monitoring the at least one physiological parameter of the patient based on data from the monitoring unit;

(b) regulating drug delivery by the drug delivery unit in accordance with a first safety shell control algorithm routine, wherein the first safety shell control algorithm routine is based at least in part on patient physiological parameter data from the monitoring unit;

(c) receiving input indicating delivery of an external drug to the patient; and

(d) regulating drug delivery by the drug delivery unit in accordance with a second safety shell control algorithm routine, wherein the second safety shell control algorithm routine is based at least in part on patient physiological parameter data from the monitoring unit and the input indicating delivery of an external drug to the patient.